Insmed, Inc. (INSM) Stock Price, Quote & AI Analysis

Live INSM stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Insmed, Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Insmed, Inc. (INSM), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

INSM
Insmed, Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
103.385000
High
105.290000
Low
102.890000
Volume
1,849,282
VWAP
-
Market Cap
$33,456,209,082.03
52W Range
$70.57 - $212.75
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Aug 5, 2026 Q2
Market
EPS Estimate: $-0.7876
Revenue Estimate: $394,979,761.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Insmed, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Insmed, Inc. Overview

Company information

Company Overview

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Company Details
Market Cap
$22.74B
Shares Outstanding
216,752,458
Weighted Shares Outstanding
213,273,469
CEO
William H. Lewis
Address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
Employees
1,271
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Insmed, Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...